Who is sponsoring NCT03699527?

NCT03699527 is sponsored by Children's Hospital of Philadelphia.

What drugs are being tested in NCT03699527?

Interventions in NCT03699527: Multiple questionnaires administered.

What condition does NCT03699527 study?

NCT03699527 studies Autism, ASD.

Is NCT03699527 still recruiting?

NCT03699527 is currently completed. Last updated 27 January 2020.

Last reviewed 2020-01-27 · How we verify

NCT03699527: Med Can Autism

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Medical Cannabis Registry and Pharmacology

Completed Last updated 27 January 2020

What this trial tests

trial testing Multiple questionnaires administered in Autism in 119 participants. Completed in 15 January 2020.

Timeline

15 July 2018

Primary endpoint
15 January 2020

15 January 2020

Quick facts

Lead sponsor	Children's Hospital of Philadelphia
Status	Completed
Study type	OBSERVATIONAL
Enrollment	119
Start date	15 July 2018
Primary completion	15 January 2020
Estimated completion	15 January 2020
Sites	1 location across United States

Drugs / interventions tested

Multiple questionnaires administered

Conditions studied

Autism — all drugs for Autism →
ASD — all drugs for ASD →

Sponsor

Children's Hospital of Philadelphia

Who can join

Under 21, any sex, with Autism or ASD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall goals of this research is to describe the 1) natural history of current use and disposition of medical cannabis products including Cannabidiol (CBD) products, being administered to children as standard of care for the treatment of Autism Spectrum Disorder (ASD), 2) understand the pharmacokinetic and pharmacodynamics of medical cannabis products and 3) provide educational feedback on what is learned to families and care providers to provide evidenced based dosing guidance for these products to the pediatric community.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Current state of evidence of cannabis utilization for treatment of autism spectrum disorders.
Agarwal R, Burke SL, Maddux M. · · 2019 · cited 18× · PMID 31664964 · DOI 10.1186/s12888-019-2259-4
Medical Cannabis in Pediatric Oncology: Friend or Foe?
Malach M, Kovalchuk I, Kovalchuk O. · · 2022 · cited 8× · PMID 35337156 · DOI 10.3390/ph15030359
Clinical Data on Canabinoids: Translational Research in the Treatment of Autism Spectrum Disorders.
Carreira LD, Matias FC, Campos MG. · · 2022 · cited 2× · PMID 35453548 · DOI 10.3390/biomedicines10040796

Verify or expand the search:

Other recruiting trials for Autism

Currently open trials in the same condition.

NCT07367256 — Using Virtual Reality to Improve Emotion Understanding in Children With Autism · NA · recruiting
NCT06853665 — The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine · Phase 4 · recruiting
NCT06523387 — Online Pivotal Response Treatment Training in Autism Spectrum Disorder · NA · recruiting
NCT07304440 — Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study · Phase 1, PHASE2 · recruiting
NCT07403396 — Static Balance Assessment in Children With ASD Using VRRS · recruiting

Other Children's Hospital of Philadelphia trials

Trials by the same sponsor.

NCT07023380 — EoE Food Test Pilot Study · NA · not yet recruiting
NCT06693752 — CEUS Evaluation of Hydrocephalus in Neonates and Infants · Phase 2 · recruiting
NCT07425691 — SPACE for Youth With Chronic Pain · recruiting
NCT07444528 — Upper Airway Ultrasound to Predict Difficult Laryngoscopy in Neonates and Infants · enrolling by invitation
NCT07321327 — Implementation Strategies for Caregiver and Teacher Use of Behavioral Interventions: Aim 2 · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03699527 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Children's Hospital of Philadelphia
Last refreshed: 27 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03699527.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing